173 related articles for article (PubMed ID: 25070490)
1. Novel multiarm polyethylene glycol-dihydroartemisinin conjugates enhancing therapeutic efficacy in non-small-cell lung cancer.
Dai L; Wang L; Deng L; Liu J; Lei J; Li D; He J
Sci Rep; 2014 Jul; 4():5871. PubMed ID: 25070490
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate.
Liu K; Dai L; Li C; Liu J; Wang L; Lei J
Sci Rep; 2016 Jul; 6():29461. PubMed ID: 27377918
[TBL] [Abstract][Full Text] [Related]
3. Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer.
Yan X; Zhao X; Fan M; Zheng W; Zhu G; Li B; Wang L
Int J Nanomedicine; 2024; 19():3847-3859. PubMed ID: 38708182
[TBL] [Abstract][Full Text] [Related]
4. Combination of onconase and dihydroartemisinin synergistically suppresses growth and angiogenesis of non-small-cell lung carcinoma and malignant mesothelioma.
Shen R; Li J; Ye D; Wang Q; Fei J
Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):894-901. PubMed ID: 27590062
[TBL] [Abstract][Full Text] [Related]
5. Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation.
Mathiyalagan R; Wang C; Kim YJ; Castro-Aceituno V; Ahn S; Subramaniyam S; Simu SY; Jiménez-Pérez ZE; Yang DC; Jung SK
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795352
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro.
Zhou HJ; Zhang JL; Li A; Wang Z; Lou XE
Cancer Chemother Pharmacol; 2010 May; 66(1):21-9. PubMed ID: 19756601
[TBL] [Abstract][Full Text] [Related]
7. Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers.
Zhao H; Rubio B; Sapra P; Wu D; Reddy P; Sai P; Martinez A; Gao Y; Lozanguiez Y; Longley C; Greenberger LM; Horak ID
Bioconjug Chem; 2008 Apr; 19(4):849-59. PubMed ID: 18370417
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
9. PEGylated-Paclitaxel and Dihydroartemisinin Nanoparticles for Simultaneously Delivering Paclitaxel and Dihydroartemisinin to Colorectal Cancer.
Phung CD; Le TG; Nguyen VH; Vu TT; Nguyen HQ; Kim JO; Yong CS; Nguyen CN
Pharm Res; 2020 Jun; 37(7):129. PubMed ID: 32548664
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel.
Yi H; Cho HJ; Cho SM; Lee DG; Abd El-Aty AM; Yoon SJ; Bae GW; Nho K; Kim B; Lee CH; Kim JS; Bartlett MG; Shin HC
BMC Cancer; 2010 May; 10():211. PubMed ID: 20482808
[TBL] [Abstract][Full Text] [Related]
11. Development of R
Liu JJ; Tang W; Fu M; Gong XQ; Kong L; Yao XM; Jing M; Cai FY; Li XT; Ju RJ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1947-1960. PubMed ID: 31079495
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer.
Li X; Zhou Y; Liu Y; Zhang X; Chen T; Chen K; Ba Q; Li J; Liu H; Wang H
EBioMedicine; 2016 Dec; 14():44-54. PubMed ID: 27939426
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid - dihydroartemisinin conjugate: Synthesis, characterization and in vitro evaluation in lung cancer cells.
Kumar R; Singh M; Meena J; Singhvi P; Thiyagarajan D; Saneja A; Panda AK
Int J Biol Macromol; 2019 Jul; 133():495-502. PubMed ID: 31004634
[TBL] [Abstract][Full Text] [Related]
14. Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis.
Jiang J; Geng G; Yu X; Liu H; Gao J; An H; Cai C; Li N; Shen D; Wu X; Zheng L; Mi Y; Yang S
Oncotarget; 2016 Dec; 7(52):87271-87283. PubMed ID: 27895313
[TBL] [Abstract][Full Text] [Related]
15. A solid lipid nanoparticle formulation of 4-(N)-docosahexaenoyl 2', 2'-difluorodeoxycytidine with increased solubility, stability, and antitumor activity.
Valdes SA; Alzhrani RF; Rodriguez A; Lansakara-P DSP; Thakkar SG; Cui Z
Int J Pharm; 2019 Oct; 570():118609. PubMed ID: 31415878
[TBL] [Abstract][Full Text] [Related]
16. Supramolecular hybrids of carbon dots and dihydroartemisinin for enhanced anticancer activity and mechanism analysis.
Li Y; Shi N; Zhang W; Zhang H; Song Y; Zhu W; Feng X
J Mater Chem B; 2020 Nov; 8(42):9777-9784. PubMed ID: 33026041
[TBL] [Abstract][Full Text] [Related]
17. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
18. Methoxypoly(ethylene glycol)-block-poly(L-glutamic acid)-loaded cisplatin and a combination with iRGD for the treatment of non-small-cell lung cancers.
Song W; Li M; Tang Z; Li Q; Yang Y; Liu H; Duan T; Hong H; Chen X
Macromol Biosci; 2012 Nov; 12(11):1514-23. PubMed ID: 23070837
[TBL] [Abstract][Full Text] [Related]
19. Study on the structure-activity relationship of dihydroartemisinin derivatives: Discovery, synthesis, and biological evaluation of dihydroartemisinin-bile acid conjugates as potential anticancer agents.
Zou X; Liu C; Li C; Fu R; Xu W; Bian H; Dong X; Zhao X; Xu Z; Zhang J; Shen Z
Eur J Med Chem; 2021 Dec; 225():113754. PubMed ID: 34399390
[TBL] [Abstract][Full Text] [Related]
20. Preparation, Characterization, and In Vivo Study of 7-Ethyl-14-Aminocamptothecin-Loaded Poly(Ethylene Glycol)2000 -Poly(Lactic Acid)2000 Polymeric Micelles Against H460 Human Nonsmall Cell Lung Carcinoma.
Cheng X; Qiu N; Yang J; Liu H; Wen J; Wang W; Wang Z; Chen L
J Pharm Sci; 2015 Nov; 104(11):3934-3942. PubMed ID: 26306026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
